Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Lee D Arnold"'
Autor:
Hélène Chabrolles, Héloïse Auclair, Serena Vegna, Thomas Lahlali, Caroline Pons, Maud Michelet, Yohann Couté, Lucid Belmudes, Gilliane Chadeuf, Yujin Kim, Ariel Di Bernardo, Pascal Jalaguier, François-Loïc Cosset, Floriane Fusil, Michel Rivoire, Lee D Arnold, Uri Lopatin, Christophe Combet, Fabien Zoulim, David Grierson, Benoit Chabot, Julie Lucifora, David Durantel, Anna Salvetti
Publikováno v:
PLoS Pathogens, Vol 16, Iss 11, p e1008593 (2020)
Despite the existence of a preventive vaccine, chronic infection with Hepatitis B virus (HBV) affects more than 250 million people and represents a major global cause of hepatocellular carcinoma (HCC) worldwide. Current clinical treatments, in most o
Externí odkaz:
https://doaj.org/article/151d937cb76042be9e95646ac4073046
Autor:
Jutta Wanner, Darlene Romashko, Douglas S Werner, Earl W May, Yue Peng, Ryan Schulz, Kenneth W Foreman, Suzanne Russo, Lee D Arnold, Maneesh Pingle, Donald E Bergstrom, Francis Barany, Stuart Thomson
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121793 (2015)
We describe the successful application of a novel approach for generating dimeric Myc inhibitors by modifying and reversibly linking two previously described small molecules. We synthesized two directed libraries of monomers, each comprised of a liga
Externí odkaz:
https://doaj.org/article/a96fd43cf1cf4560b2de89acf1760b8b
Autor:
Jonathan A. Pachter, Peter J. Houghton, Lee D. Arnold, Robert Wild, Neil W. Gibson, David M. Epstein, Lorina Dudkin, Mark Bittner, Jennifer Workman, Jennifer Kahler, Christine Mantis, Yan Yao, Andy Cooke, Andrew P. Crew, Prafulla C. Gokhale, Shripad V. Bhagwat
Supplementary Figures 1-9 and Tables 1-3 from Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9ab41947de32aae0fe5fca829aab12
https://doi.org/10.1158/1535-7163.22496358.v1
https://doi.org/10.1158/1535-7163.22496358.v1
Autor:
Jonathan A. Pachter, Peter J. Houghton, Lee D. Arnold, Robert Wild, Neil W. Gibson, David M. Epstein, Lorina Dudkin, Mark Bittner, Jennifer Workman, Jennifer Kahler, Christine Mantis, Yan Yao, Andy Cooke, Andrew P. Crew, Prafulla C. Gokhale, Shripad V. Bhagwat
Supplementary Methods and Figure Legends 1-9 from Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a574faa50b2771bf5de2007cc92ce22
https://doi.org/10.1158/1535-7163.22496355.v1
https://doi.org/10.1158/1535-7163.22496355.v1
Autor:
Jonathan A. Pachter, Peter J. Houghton, Lee D. Arnold, Robert Wild, Neil W. Gibson, David M. Epstein, Lorina Dudkin, Mark Bittner, Jennifer Workman, Jennifer Kahler, Christine Mantis, Yan Yao, Andy Cooke, Andrew P. Crew, Prafulla C. Gokhale, Shripad V. Bhagwat
The phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway is frequently activated in human cancers, and mTOR is a clinically validated target. mTOR forms two distinct multiprotein complexes, mTORC1 and mTORC2, which regulate cell growth, metabolism, prol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4546d5b478a915123119734a9363799a
https://doi.org/10.1158/1535-7163.c.6535242
https://doi.org/10.1158/1535-7163.c.6535242
Autor:
Jonathan A. Pachter, Neil W. Gibson, Lee D. Arnold, Alexandra Eyzaguirre, Elizabeth Buck, Caroline Pirritt, Yan Yao, Matthew O'Connor, Gilda Mak, Lixin Feng, Andrew Cooke, Maryland Rosenfeld-Franklin, Mark J. Mulvihill, Qun-sheng Ji
Insulin-like growth factor-I receptor (IGF-IR) and its ligands, IGF-I and IGF-II, are up-regulated in a variety of human cancers. In tumors, such as colorectal, non–small cell lung, ovarian, and pediatric cancers, which may drive their own growth a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c6d78e18d5213a54ae84ba8a5326f5
https://doi.org/10.1158/1535-7163.c.6532205.v1
https://doi.org/10.1158/1535-7163.c.6532205.v1
Autor:
Jonathan A. Pachter, Neil W. Gibson, Lee D. Arnold, Alexandra Eyzaguirre, Elizabeth Buck, Caroline Pirritt, Yan Yao, Matthew O'Connor, Gilda Mak, Lixin Feng, Andrew Cooke, Maryland Rosenfeld-Franklin, Mark J. Mulvihill, Qun-sheng Ji
Supplementary Material from A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051a776eb2077a5803345e192cea0829
https://doi.org/10.1158/1535-7163.22486034.v1
https://doi.org/10.1158/1535-7163.22486034.v1
Autor:
Neil W. Gibson, Lee D. Arnold, Arlindo L. Castelhano, David L. Emerson, Frank Richardson, Tao Zhang, An-Hu Li, Regina Sennello, Karen Hart, Dwight Henninger, Bojana Vulevic, Anna Chan, Matthew O'Connor, Carrie Pirrit, Mary C. Srebernak, Chris Hidden, Paul Briner, John F. Keily, Mark A. Bittner, Eric N. Brown, April Franks, Shannon L. Winski, Jennifer Kahler, Linda Castaldo, Graham M. Wynne, Andrew R. Cooke, Maryland Franklin, Andrew P.A. Crew, Andrew J. Garton
Supplementary Figure Legends from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d345aaadab65f3803036dfbbb909af
https://doi.org/10.1158/0008-5472.22366926.v1
https://doi.org/10.1158/0008-5472.22366926.v1
Autor:
Neil W. Gibson, Lee D. Arnold, Arlindo L. Castelhano, David L. Emerson, Frank Richardson, Tao Zhang, An-Hu Li, Regina Sennello, Karen Hart, Dwight Henninger, Bojana Vulevic, Anna Chan, Matthew O'Connor, Carrie Pirrit, Mary C. Srebernak, Chris Hidden, Paul Briner, John F. Keily, Mark A. Bittner, Eric N. Brown, April Franks, Shannon L. Winski, Jennifer Kahler, Linda Castaldo, Graham M. Wynne, Andrew R. Cooke, Maryland Franklin, Andrew P.A. Crew, Andrew J. Garton
Supplementary Tables 1-2 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce34b51937e71be251c0829e3f406e8
https://doi.org/10.1158/0008-5472.22366920
https://doi.org/10.1158/0008-5472.22366920
Autor:
Neil W. Gibson, Lee D. Arnold, Arlindo L. Castelhano, David L. Emerson, Frank Richardson, Tao Zhang, An-Hu Li, Regina Sennello, Karen Hart, Dwight Henninger, Bojana Vulevic, Anna Chan, Matthew O'Connor, Carrie Pirrit, Mary C. Srebernak, Chris Hidden, Paul Briner, John F. Keily, Mark A. Bittner, Eric N. Brown, April Franks, Shannon L. Winski, Jennifer Kahler, Linda Castaldo, Graham M. Wynne, Andrew R. Cooke, Maryland Franklin, Andrew P.A. Crew, Andrew J. Garton
Supplementary Figures 1-3 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2466cc8df2c7445a3647818bc7207ba8
https://doi.org/10.1158/0008-5472.22366923.v1
https://doi.org/10.1158/0008-5472.22366923.v1